Suppr超能文献

腹腔镜胃癌根治术治疗腺癌后的疗效与生存情况。对65例行传统或机器人辅助微创手术的患者进行分析。

Outcomes and survival after laparoscopic gastrectomy for adenocarcinoma. Analysis on 65 patients operated on by conventional or robot-assisted minimal access procedures.

作者信息

Pugliese R, Maggioni D, Sansonna F, Ferrari G C, Forgione A, Costanzi A, Magistro C, Pauna J, Di Lernia S, Citterio D, Brambilla C

机构信息

Divisione di Chirurgia Generale e Videolaparoscopica, Ospedale di Niguarda Ca' Granda, Milano, Italy.

出版信息

Eur J Surg Oncol. 2009 Mar;35(3):281-8. doi: 10.1016/j.ejso.2008.02.001. Epub 2008 Mar 14.

Abstract

AIMS

Despite laparoscopic surgery for gastric cancer has gained worldwide acceptance, long term results and survival are seldom reported. This study was designed to assess long term outcomes after laparoscopic gastrectomy with D2 dissection. The short term results of conventional and robot-assisted minimally invasive procedures were also examined.

PATIENTS AND METHODS

The charts of 65 patients who underwent laparoscopic surgery for non-metastatic adenocarcinoma were reviewed retrospectively. This series included 35 patients with early gastric cancer (EGC) and 30 with advanced gastric cancer (AGC). A 4/5 laparoscopic subtotal gastrectomy (LSG) with D2 nodal clearance was the procedure of choice for distal cancers. Laparoscopic total gastrectomy (LTG) with modified D1 lymphadenectomy was performed for mid-proximal EGC.

RESULTS

Sixty gastrectomies were carried out laparoscopically, 56 LSG and 4 LTG. Conversion to laparotomy was required in 5 patients with distal cancer. No intraoperative complication was registered. Morbidity included 2 duodenal leaks that healed conservatively. Two postoperative deaths were registered. An average number 31.3+/-8.8 lymph nodes were collected. The mean hospital stay was 10 days (range 7-24). The mean follow up was 30 months (range 2-86) and the cumulative overall 5 year survival rate was 78%. Survival at 5 years for EGC was 94% and survival at 4 years for AGC was 53% (57% for non-converted patients).

CONCLUSIONS

Laparoscopic gastrectomy for cancer represents a valid alternative to open surgery with minimal morbidity and acceptable long term survival. Considering the risk of preoperative under diagnoses a D2 lymphadenectomy is suggested also for EGC. This study validated the effectiveness of minimally invasive technique in the management of gastric cancer.

摘要

目的

尽管腹腔镜胃癌手术已在全球范围内得到认可,但长期结果和生存率鲜有报道。本研究旨在评估腹腔镜胃切除术联合D2淋巴结清扫术后的长期疗效。同时也对传统和机器人辅助微创手术的短期结果进行了研究。

患者与方法

回顾性分析65例行腹腔镜手术治疗非转移性腺癌患者的病历。该系列包括35例早期胃癌(EGC)患者和30例进展期胃癌(AGC)患者。对于远端癌,选择行4/5腹腔镜胃大部切除术(LSG)并进行D2淋巴结清扫。对于中近端EGC,行腹腔镜全胃切除术(LTG)并进行改良D1淋巴结清扫。

结果

共进行了60例腹腔镜胃切除术,其中56例LSG和4例LTG。5例远端癌患者需要中转开腹。无术中并发症记录。术后并发症包括2例十二指肠漏,经保守治疗愈合。记录到2例术后死亡。平均收集31.3±8.8枚淋巴结。平均住院时间为10天(范围7 - 24天)。平均随访30个月(范围2 - 86个月),累计5年总生存率为78%。EGC患者5年生存率为94%,AGC患者4年生存率为53%(未中转患者为57%)。

结论

腹腔镜胃癌手术是开放手术的有效替代方法,并发症发生率低,长期生存率可接受。考虑到术前漏诊风险,建议EGC患者也行D2淋巴结清扫。本研究验证了微创技术在胃癌治疗中的有效性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验